Key result
Therapeutic 1-MHz ultrasound with intravenous microbubbles produced significantly more ectopy and clinical arrhythmias (15%) compared to diagnostic ultrasound.
Why the study?
Does therapeutic ultrasound compared to diagnostic ultrasound increase the incidence of cardiac arrhythmias in patients receiving intravenous microbubbles?
Does therapeutic ultrasound compared to diagnostic ultrasound increase the incidence of cardiac arrhythmias in patients receiving intravenous microbubbles?
p-value: p=<.001
Therapeutic low-frequency ultrasound combined with intravenous microbubbles can induce clinically significant arrhythmias, whereas diagnostic ultrasound primarily produces isolated ventricular ectopy.
Therapeutic ultrasound plus microbubbles may raise arrhythmia risk; leaves open need for randomized confirmation before wider adoption.
OBJECTIVE: The purpose of this study was to determine the type of arrhythmias induced with therapeutic versus diagnostic transthoracic low-frequency ultrasound (TLFUS) transducers in the presence of intravenous microbubbles. METHODS: Intravenous perfluorocarbon-exposed sonicated dextrose albumin (PESDA) microbubbles were infused or given as a bolus injection while TLFUS was applied in the standard parasternal and apical views with either a 1-MHz therapeutic ultrasound transducer or high-mechanical-index diagnostic ultrasound (1.7 MHz). RESULTS: Significantly more ectopy was produced by the therapeutic transducer, especially at higher-intensity settings in the continuous wave mode after bolus injections of PESDA (P < .001 compared with lower intensities and lower continuous infusion rates). Six patients (15%) had either clinical supraventricular tachycardia or nonsustained ventricular tachycardia after intravenous PESDA with therapeutic TLFUS. In comparison, diagnostic high-mechanical-index ultrasound produced only isolated ventricular ectopy and no sustained ventricular arrhythmias. CONCLUSIONS: Intravenously injected microbubbles and low-frequency therapeutic transducers operating at longer duty cycles and wide beam widths have the capability of eliciting clinically important arrhythmias in patients at high risk for such events.
No takes yet. Share an insight, caveat, or question.
Chapman et al. (2005) studied this question. Therapeutic ultrasound (1-MHz) with intravenous PESDA microbubbles vs. Diagnostic ultrasound (1.7 MHz) with intravenous PESDA microbubbles was evaluated on Cardiac arrhythmias (ectopy, supraventricular tachycardia, or nonsustained ventricular tachycardia) (p=<.001). Therapeutic 1-MHz ultrasound with intravenous microbubbles produced significantly more ectopy and clinical arrhythmias (15%) compared to diagnostic ultrasound.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: